table of content
1 Study Coverage
1.1 Biologic Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Biologic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Humira
1.2.3 Remicade
1.2.4 Rituxan
1.2.5 Enbrel
1.2.6 Lantus
1.2.7 Avastin
1.2.8 Herceptin
1.2.9 Others
1.3 Market by Application
1.3.1 Global Biologic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Diabetes
1.3.3 Inflammation
1.3.4 Auto-Immune Diseases
1.3.5 Blood Diseases
1.3.6 Cardiovascular Diseases
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Biologic Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Biologic Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Biologic Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Biologic Drugs Sales by Region
2.4.1 Global Biologic Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Biologic Drugs by Region (2023-2028)
2.5 Global Biologic Drugs Revenue by Region
2.5.1 Global Biologic Drugs Revenue by Region (2017-2022)
2.5.2 Global Biologic Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Biologic Drugs Sales by Manufacturers
3.1.1 Global Top Biologic Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Biologic Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biologic Drugs in 2021
3.2 Global Biologic Drugs Revenue by Manufacturers
3.2.1 Global Biologic Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Biologic Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Biologic Drugs Revenue in 2021
3.3 Global Biologic Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Biologic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Biologic Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Biologic Drugs Sales by Type
4.1.1 Global Biologic Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Biologic Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Biologic Drugs Sales Market Share by Type (2017-2028)
4.2 Global Biologic Drugs Revenue by Type
4.2.1 Global Biologic Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Biologic Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Biologic Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Biologic Drugs Price by Type
4.3.1 Global Biologic Drugs Price by Type (2017-2022)
4.3.2 Global Biologic Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Biologic Drugs Sales by Application
5.1.1 Global Biologic Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Biologic Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Biologic Drugs Sales Market Share by Application (2017-2028)
5.2 Global Biologic Drugs Revenue by Application
5.2.1 Global Biologic Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Biologic Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Biologic Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Biologic Drugs Price by Application
5.3.1 Global Biologic Drugs Price by Application (2017-2022)
5.3.2 Global Biologic Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Biologic Drugs Market Size by Type
6.1.1 North America Biologic Drugs Sales by Type (2017-2028)
6.1.2 North America Biologic Drugs Revenue by Type (2017-2028)
6.2 North America Biologic Drugs Market Size by Application
6.2.1 North America Biologic Drugs Sales by Application (2017-2028)
6.2.2 North America Biologic Drugs Revenue by Application (2017-2028)
6.3 North America Biologic Drugs Market Size by Country
6.3.1 North America Biologic Drugs Sales by Country (2017-2028)
6.3.2 North America Biologic Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Biologic Drugs Market Size by Type
7.1.1 Europe Biologic Drugs Sales by Type (2017-2028)
7.1.2 Europe Biologic Drugs Revenue by Type (2017-2028)
7.2 Europe Biologic Drugs Market Size by Application
7.2.1 Europe Biologic Drugs Sales by Application (2017-2028)
7.2.2 Europe Biologic Drugs Revenue by Application (2017-2028)
7.3 Europe Biologic Drugs Market Size by Country
7.3.1 Europe Biologic Drugs Sales by Country (2017-2028)
7.3.2 Europe Biologic Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Biologic Drugs Market Size by Type
8.1.1 Asia Pacific Biologic Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Biologic Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Biologic Drugs Market Size by Application
8.2.1 Asia Pacific Biologic Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Biologic Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Biologic Drugs Market Size by Region
8.3.1 Asia Pacific Biologic Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Biologic Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Biologic Drugs Market Size by Type
9.1.1 Latin America Biologic Drugs Sales by Type (2017-2028)
9.1.2 Latin America Biologic Drugs Revenue by Type (2017-2028)
9.2 Latin America Biologic Drugs Market Size by Application
9.2.1 Latin America Biologic Drugs Sales by Application (2017-2028)
9.2.2 Latin America Biologic Drugs Revenue by Application (2017-2028)
9.3 Latin America Biologic Drugs Market Size by Country
9.3.1 Latin America Biologic Drugs Sales by Country (2017-2028)
9.3.2 Latin America Biologic Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Biologic Drugs Market Size by Type
10.1.1 Middle East and Africa Biologic Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Biologic Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Biologic Drugs Market Size by Application
10.2.1 Middle East and Africa Biologic Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Biologic Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Biologic Drugs Market Size by Country
10.3.1 Middle East and Africa Biologic Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Biologic Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Overview
11.1.3 Roche Biologic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Roche Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Corporation Information
11.2.2 Abbott Laboratories Overview
11.2.3 Abbott Laboratories Biologic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Abbott Laboratories Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbott Laboratories Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Overview
11.3.3 Johnson & Johnson Biologic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Johnson & Johnson Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Johnson & Johnson Recent Developments
11.4 Merck & Co.
11.4.1 Merck & Co. Corporation Information
11.4.2 Merck & Co. Overview
11.4.3 Merck & Co. Biologic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Merck & Co. Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck & Co. Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Biologic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Amgen
11.6.1 Amgen Corporation Information
11.6.2 Amgen Overview
11.6.3 Amgen Biologic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Amgen Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Amgen Recent Developments
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Overview
11.7.3 Sanofi Biologic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sanofi Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sanofi Recent Developments
11.8 Novartis
11.8.1 Novartis Corporation Information
11.8.2 Novartis Overview
11.8.3 Novartis Biologic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Novartis Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Novartis Recent Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Corporation Information
11.9.2 Eli Lilly Overview
11.9.3 Eli Lilly Biologic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Eli Lilly Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Eli Lilly Recent Developments
11.10 Amgen
11.10.1 Amgen Corporation Information
11.10.2 Amgen Overview
11.10.3 Amgen Biologic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Amgen Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Amgen Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Biologic Drugs Industry Chain Analysis
12.2 Biologic Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Biologic Drugs Production Mode & Process
12.4 Biologic Drugs Sales and Marketing
12.4.1 Biologic Drugs Sales Channels
12.4.2 Biologic Drugs Distributors
12.5 Biologic Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Biologic Drugs Industry Trends
13.2 Biologic Drugs Market Drivers
13.3 Biologic Drugs Market Challenges
13.4 Biologic Drugs Market Restraints
14 Key Findings in The Global Biologic Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
